BEGIN:VCALENDAR
PRODID:-//eluceo/ical//2.0/EN
VERSION:2.0
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:04cd6e043329e72fe7efd500782ea6ed
DTSTAMP:20260607T201525Z
SUMMARY:Frontiers in Neuroscience seminar: Measuring prevention - biomarker
  outcomes in clinical trials of preclinical AD 
DESCRIPTION:Contact: diana.jerman@med.lu.se\n\nWelcome to a Frontiers in Ne
 uroscience talk by Professor Dave Cash\, University College London\, UKLec
 ture title: Measuring prevention - biomarker outcomes in clinical trials o
 f preclinical ADLecture host: Niklas Mattsson-Carlgren&nbsp\;About the spe
 aker:David Cash&nbsp\;is a Professor at the UCL Queen Square Institute of 
 Neurology and an Alzheimer’s Society Dementia Research Leaders Fellow. H
 e holds a bachelor’s degree in Biomedical and Electrical Engineering fro
 m Duke University and an MS and PhD in Biomedical Engineering from Vanderb
 ilt University.In addition to his academic experience\, he has also spent 
 time in industry. Professor Cash spent five years at IXICO Ltd\, where he 
 led imaging acquisition and analysis for multinational clinical trials in 
 Alzheimer’s disease and oncology in collaboration with pharmaceutical sp
 onsors. He now serves as a consultant to Perceptive Imaging\, one of the w
 orlds largest imaging contract research organisations\, which has a focus 
 on clinical trials in Alzheimer’s disease and Parkinson’s disease.&nbs
 p\;His research focuses on the development and application of imaging biom
 arkers to detect and track the pre-symptomatic stages of dementia\, and on
  optimising the use of imaging in large-scale\, multi-site observational s
 tudies and clinical trials. He plays a key role in the design\, acquisitio
 n\, and analysis of major UCL-led studies\, including Insight 46—the n
 euroimaging substudy of the 1946 British Birth Cohort—and the GENetic Fr
 ontotemporal Initiative (GENFI).Professor Cash also contributes to several
  national and international imaging initiatives\, including the imaging co
 re of the Dominantly Inherited Alzheimer Network (DIAN)\, the MRI core of 
 the Alzheimer’s Disease Neuroimaging Initiative (ADNI)\, the ISTAART Neu
 roimaging PIA\, and the ISTAART Advisory Council. In addition to his resea
 rch activities\, he leads innovative training programmes\, including Healt
 h and Bioscience IDEAS\, a UK Research and Innovation–funded initiative 
 developing interactive\, hands-on approaches to improve researchers’ use
  of medical imaging data.\n\nMore information about the event: https://www
 .multipark.lu.se/calendar/frontiers-neuroscience-seminar-measuring-prevent
 ion-biomarker-outcomes-clinical-trials-preclinical
DTSTART;TZID=GMT:20260508T080000
DTEND;TZID=GMT:20260508T080000
LOCATION:Room: E16003\, Forum Medicum
END:VEVENT
END:VCALENDAR